The Adverse Effect of COVID Pandemic on the Care of Patients With Kidney Diseases in India DOI Creative Commons
Narayan Prasad,

Mansi Bhatt,

Sanjay Kumar Agarwal

и другие.

Kidney International Reports, Год журнала: 2020, Номер 5(9), С. 1545 - 1550

Опубликована: Июль 6, 2020

IntroductionThe coronavirus disease 2019 (COVID-19) pandemic has affected the care of patients with noncommunicable diseases, including those suffering from kidney-related ailments. Many parts world, India, adopted lockdown to curb community transmission disease. The transportation, access health facilities, and availability medicines consumables as well outpatient inpatient services. We aimed analyze effect imposed due COVID-19 on kidney diseases in India.MethodsWe surveyed 19 major hospitals (8 public 11 private sector) determine disease, dialysis after first 3 weeks lockdown.ResultsThe total number these centers came down 2517 2404. Approximately 710 (28.2%) missed 1 or more sessions, 69 (2.74%) required emergency 104 (4.13%) stopped reporting for dialysis, 9 (0.36%) were confirmed have died. Outpatient attendance hospital by 92.3%, service reduced 61%. Tele-consultation was started but accessed only a small patients.ConclusionLack preparedness before resulted an interruption services posed immediate adverse outcome India. long-term impact less severe forms remains unknown.

Язык: Английский

Acute kidney injury DOI Open Access
John A. Kellum, Paola Romagnani,

Gloria Ashuntantang

и другие.

Nature Reviews Disease Primers, Год журнала: 2021, Номер 7(1)

Опубликована: Июль 15, 2021

Язык: Английский

Процитировано

1066

Single-Cell Profiling Reveals Sex, Lineage, and Regional Diversity in the Mouse Kidney DOI Creative Commons

Andrew Ransick,

Nils O. Lindström, Jing Liu

и другие.

Developmental Cell, Год журнала: 2019, Номер 51(3), С. 399 - 413.e7

Опубликована: Ноя. 1, 2019

Язык: Английский

Процитировано

353

Chronic kidney disease and the global public health agenda: an international consensus DOI Open Access
Anna Francis, Meera N. Harhay, Albert Ong

и другие.

Nature Reviews Nephrology, Год журнала: 2024, Номер 20(7), С. 473 - 485

Опубликована: Апрель 3, 2024

Язык: Английский

Процитировано

306

Chronic Kidney Disease: Detection and Evaluation DOI Open Access

Raena Pettitt,

OMS-I Alonna P. Brumbaugh,

OMS-I Michaela F. Gartman

и другие.

Osteopathic Family Physician, Год журнала: 2020, Номер 12(1), С. 14 - 19

Опубликована: Янв. 3, 2020

Язык: Английский

Процитировано

192

A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives DOI Creative Commons
Marc Evans,

Ruth D. Lewis,

Angharad R. Morgan

и другие.

Advances in Therapy, Год журнала: 2021, Номер 39(1), С. 33 - 43

Опубликована: Ноя. 5, 2021

Chronic kidney disease (CKD) is a complex which affects approximately 13% of the world's population. Over time, CKD can cause renal dysfunction and progression to end-stage cardiovascular disease. Complications associated with may contribute acceleration risk cardiovascular-related morbidities. Early asymptomatic, symptoms only present at later stages when complications arise, such as decline in function presence other comorbidities In advanced disease, significantly impaired, patients be treated dialysis or transplant. With limited treatment options available, an increasing prevalence both elderly population set rise. This review discusses current challenges unmet patient need CKD.

Язык: Английский

Процитировано

170

Sustainable Development Goals relevant to kidney health: an update on progress DOI Open Access
Valérie A. Luyckx, Ziyad Al‐Aly, Aminu K. Bello

и другие.

Nature Reviews Nephrology, Год журнала: 2020, Номер 17(1), С. 15 - 32

Опубликована: Ноя. 13, 2020

Язык: Английский

Процитировано

165

Recent advances in nanotechnology-based drug delivery systems for the kidney DOI
Fatemeh Oroojalian, Fahimeh Charbgoo, Maryam Hashemi

и другие.

Journal of Controlled Release, Год журнала: 2020, Номер 321, С. 442 - 462

Опубликована: Фев. 14, 2020

Язык: Английский

Процитировано

147

Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions DOI
Yi Huang, Jonathan Wang, Kairui Jiang

и другие.

Journal of Controlled Release, Год журнала: 2021, Номер 334, С. 127 - 137

Опубликована: Апрель 21, 2021

Язык: Английский

Процитировано

122

A bibliometric analysis of sustainable development goals (SDGs): a review of progress, challenges, and opportunities DOI Open Access
Manoranjan Mishra, Desul Sudarsan, Celso Augusto Guimarães Santos

и другие.

Environment Development and Sustainability, Год журнала: 2023, Номер 26(5), С. 11101 - 11143

Опубликована: Май 7, 2023

Язык: Английский

Процитировано

118

3D bioprinted organ‐on‐chips DOI
Sajjad Rahmani Dabbagh, Misagh Rezapour Sarabi, Mehmet Tugrul Birtek

и другие.

Aggregate, Год журнала: 2022, Номер 4(1)

Опубликована: Май 1, 2022

Abstract Organ‐on‐a‐chip (OOC) platforms recapitulate human in vivo‐like conditions more realistically compared to many animal models and conventional two‐dimensional cell cultures. OOC setups benefit from continuous perfusion of cultures through microfluidic channels, which promotes viability activities. Moreover, chips allow the integration biosensors for real‐time monitoring analysis interactions responses administered drugs. Three‐dimensional (3D) bioprinting enables fabrication multicell with sophisticated 3D structures that closely mimic tissues. 3D‐bioprinted are promising tools understanding functions organs, disruptive influences diseases on organ functionality, screening efficacy as well toxicity drugs organs. Here, common techniques, advantages, limitations each method reviewed. Additionally, recent advances, applications, potentials emulating various organs presented. Last, current challenges future perspectives discussed.

Язык: Английский

Процитировано

75